Cargando…

Identifying immune cells-related phenotype to predict immunotherapy and clinical outcome in gastric cancer

BACKGROUND: The tumor microenvironment is mainly composed of tumor-infiltrating immune cells (TIICs), fibroblast, extracellular matrix, and secreted factors. TIICs are often associated with sensitivity to immunotherapy and the prognosis of multiple cancers, yet the predictive role of individual cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Sutian, Ding, Xuzhong, Wu, Qianqian, Cheng, Tong, Xu, Manyu, Huang, Jianfei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402937/ https://www.ncbi.nlm.nih.gov/pubmed/36032097 http://dx.doi.org/10.3389/fimmu.2022.980986

Ejemplares similares

GARP Correlates With Tumor-Infiltrating T-Cells and Predicts the Outcome of Gastric Cancer
por: Jiang, Sutian, et al.
Publicado: (2021)

A Novel Pyroptosis-related Prognostic Model for Hepatocellular Carcinoma
por: Wu, Qianqian, et al.
Publicado: (2021)

Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma
por: Liang, Zhongqing, et al.
Publicado: (2022)

Tumor Microenvironment Characterization for Assessment of Recurrence and Survival Outcome in Gastric Cancer to Predict Chemotherapy and Immunotherapy Response
por: Chen, Yan, et al.
Publicado: (2022)

The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy
por: Botticelli, Andrea, et al.
Publicado: (2022)

Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Zeng, Weibiao, et al.
Publicado: (2023)

Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy
por: Ji, Hang, et al.
Publicado: (2021)

Characterization of Immune-Related Molecular Subtypes and a Prognostic Signature Correlating With the Response to Immunotherapy in Patients With Gastric Cancer
por: Wang, Gaoming, et al.
Publicado: (2022)

Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma
por: Liu, Dan, et al.
Publicado: (2021)

Prognostic signatures of sphingolipids: Understanding the immune landscape and predictive role in immunotherapy response and outcomes of hepatocellular carcinoma
por: Zhang, Xin, et al.
Publicado: (2023)

Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer
por: Song, Junquan, et al.
Publicado: (2022)

Multidimensional Analyses of Tumor Immune Microenvironment Reveal the Possible Rationality of Immunotherapy and Identify High Immunotherapy Response Subtypes for Renal Papillary Cell Carcinoma
por: Wei, Baojun, et al.
Publicado: (2021)

Lysine Acetylation/Deacetylation Modification of Immune-Related Molecules in Cancer Immunotherapy
por: Ding, Peng, et al.
Publicado: (2022)

Identifying tumor antigens and immune subtypes of renal cell carcinoma for immunotherapy development
por: Chen, Xinglin, et al.
Publicado: (2022)

Body composition parameters for predicting the efficacy of neoadjuvant chemotherapy with immunotherapy for gastric cancer
por: Lin, Guang-Tan, et al.
Publicado: (2022)

Identification of lactylation related model to predict prognostic, tumor infiltrating immunocytes and response of immunotherapy in gastric cancer
por: Yang, Hao, et al.
Publicado: (2023)

The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer
por: Zhao, Zidan, et al.
Publicado: (2023)

The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma
por: Li, Xizhe, et al.
Publicado: (2022)

Identify the immune characteristics and immunotherapy value of CD93 in the pan-cancer based on the public data sets
por: Guo, Aiyuan, et al.
Publicado: (2022)

Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes
por: Kim, Samuel I., et al.
Publicado: (2021)

Associations of HER2 Mutation With Immune-Related Features and Immunotherapy Outcomes in Solid Tumors
por: Wang, Deqiang, et al.
Publicado: (2022)

Construction of a nomogram to predict the survival of metastatic gastric cancer patients that received immunotherapy
por: Gou, Miaomiao, et al.
Publicado: (2022)

Versican enrichment predicts poor prognosis and response to adjuvant therapy and immunotherapy in gastric cancer
por: Song, Junquan, et al.
Publicado: (2022)

Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer
por: Xia, Yan, et al.
Publicado: (2022)

CLCF1 Is a Novel Potential Immune-Related Target With Predictive Value for Prognosis and Immunotherapy Response in Glioma
por: Jiang, Yuan, et al.
Publicado: (2022)

Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma
por: Li, Huihuang, et al.
Publicado: (2022)

T Cell Dysfunction in Cancer Immunity and Immunotherapy
por: Xia, Anliang, et al.
Publicado: (2019)

Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients
por: Hu, Bo, et al.
Publicado: (2022)

Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy
por: Gnjatic, Sacha, et al.
Publicado: (2017)

CD226 identifies functional CD8(+)T cells in the tumor microenvironment and predicts a better outcome for human gastric cancer
por: Huang, Hao, et al.
Publicado: (2023)

Immunotherapy: Reshape the Tumor Immune Microenvironment
por: LV, Bingzhe, et al.
Publicado: (2022)

Pan-Cancer Analysis Identifies Liver Metastases as Negative Predictive Factor for Immune Checkpoint Inhibitors Treatment Outcome
por: Chen, Xiao-Juan, et al.
Publicado: (2021)

NOTCH4 mutation as predictive biomarker for immunotherapy benefits in NRAS wildtype melanoma
por: Li, Hongxia, et al.
Publicado: (2022)

Robust Prediction of Immune Checkpoint Inhibition Therapy for Non-Small Cell Lung Cancer
por: Jiang, Jiehan, et al.
Publicado: (2021)

Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas
por: Kuang, Yirui, et al.
Publicado: (2023)

TREM2: Keeping Pace With Immune Checkpoint Inhibitors in Cancer Immunotherapy
por: Qiu, Hui, et al.
Publicado: (2021)

A New Crustin Gene Homolog SpCrus8 Identified in Scylla paramamosain Exerting In Vivo Protection Through Opsonization and Immunomodulation
por: Jiang, Manyu, et al.
Publicado: (2022)

Tumor Immune Microenvironment and Immunotherapy in Brain Metastasis From Non-Small Cell Lung Cancer
por: Wang, Yuchang, et al.
Publicado: (2022)

Screening and Validation of the Hypoxia-Related Signature of Evaluating Tumor Immune Microenvironment and Predicting Prognosis in Gastric Cancer
por: Pei, Jun-Peng, et al.
Publicado: (2021)

A novel immunogenic cell death–related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer
por: Dong, Bingqi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u5ehc7mlgdtmm3pp2bln0mltu1